UDI Status in the United Kingdom

1. Key takeaways

As of 29 October 2026, Unique Device Identification (UDI) is not mandatory in Great Britain. MHRA registration (DORS) requires only the Basic UDI-DI where applicable. A proposed pre-market statutory instrument would make UDI mandatory, and the government’s consultation response indicated transition periods of 3 years for general devices and 5 years for IVDs; it also proposed lifting the requirement to physically affix UKCA marking, conditional on the device carrying UDI that is retrievable in a public database. That instrument is not yet in force, and the transition clock has not started. The practical consequence is a rare regulatory gift: a preparation window in which coding decisions can be made calmly, tested against EU operations and funded properly, without any live deadline. But the window also invites two failure modes, and both appear in the sections below: acting on rumours of mandatory dates that have no official source, and doing nothing at all so that the eventual transition arrives with no coding infrastructure in place. GRZAN’s recommended posture, described in section 4, is zero-cost pre-preparation for companies already coding for the EU and deliberate scheme selection for those that are not. The sections below separate what the current rules require, what the proposal would change and what remains unverified, which is the order in which any coding decision should be made.

2. Legal basis

• Currently effective text: UK MDR 2002 (SI 2002/618, as amended) contains no mandatory UDI provisions.
• Official guidance: GOV.UK, Register medical devices to place on the market, in the registration information section, which asks for the UDI-DI where applicable and encourages existing registrants to add their UDI-DI.
• Proposed status: a draft pre-market statutory instrument (as of the verification date there is no in-force text to cite); the transition periods in the government’s consultation response are a practical estimate.

3. Expert insights

Insight one: a preparation window sits between current practice and future requirements. The MHRA asks for the UDI-DI at registration where applicable, but this is a data field, not a mandatory coding obligation. Companies that have already assigned UDI for the EU market can simply use the existing codes. That single step satisfies the current data requirement and simultaneously prepares for mandatory UDI under the future regime, at essentially zero marginal cost. For these companies the strategic question is not whether to code but how to keep the EU and UK code sets aligned as packaging and configuration evolve, so that a future UK mandate can be met from the existing master data rather than from a new coding exercise. GRZAN recommends verifying that the EU-assigned codes cover every UK configuration, since packaging variants sometimes differ between the two markets.

Insight two: in the future scheme, UDI and UKCA marking are linked. The direction of the government’s consultation response is that where a manufacturer has assigned UDI and the UDI is retrievable in a public database, the requirement to physically affix the UKCA mark may be lifted. In other words, UDI in the future framework functions as a precondition for substituting the mark, not as an isolated data requirement. This link is worth planning for: if the provision lands as proposed, coding infrastructure becomes the mechanism through which labelling flexibility is earned, and the companies with clean, public, retrievable UDI data will hold an operational advantage over those that scramble to assign codes after the instrument takes effect. Manufacturers should therefore track the proposal’s progress not only for UDI itself but for the marking substitution it may enable.

Insight three: beware of non-official dates circulating in the market. During verification, GRZAN found claims that from 1 October 2026 the UK would mandate UKCA UDI together with structured electronic instructions for use and would stop accepting paper IFUs. That claim does not appear in any MHRA or legislation.gov.uk official announcement; its sources are second-hand aggregator sites, and GRZAN does not accept it, listing it on the unverified claims register. The lesson generalises: any claimed compliance deadline should be traceable to an official instrument or announcement before it drives spending, because recycled rumours in this sector tend to be plausible, persistent and wrong. GRZAN’s unverified claims register records the source, the date found and the reason for rejection, so the same rumour can be answered consistently when customers or partners raise it.

4. Practical recommendations

GRZAN recommends a zero-cost pre-preparation strategy. For products already coded for the EU, enter the existing UDI-DI into DORS directly and treat the field as a maintained data element thereafter. For products not yet coded, where there is no near-term EU plan, coding can be deferred, but the coding scheme selection should be completed now: the issuing agency, the data structure and the carrier form. Making these three choices in advance costs almost nothing and removes the longest lead-time item from any future mandate, so that when the legislation takes effect the execution step, assigning and carrying the codes, is all that remains. The selection record should note the carrier options considered and rejected as well, since that reasoning will be useful once the final mandate’s requirements are known. GRZAN suggests recording the selection decision and its rationale in the quality system, so the choice survives staff turnover.

5. Verification checklist

• □ Confirmed that UDI is currently not mandatory in the UK
• □ An available Basic UDI-DI is entered in DORS
• □ The issuing agency and data structure have been selected
• □ Monitoring of the proposed legislation is in place
• □ Claims of mandatory dates without official sources have not been accepted

Regulatory information verified as of 29 October 2026.

GRZAN supports manufacturers entering the UK market with the preparation and maintenance of registration documentation and conformity documentation. Our services for the UK market include:

• UK Responsible Person (UKRP) appointment and authorisation letter support
• Full MHRA registration (DORS) filing and account lifecycle management
• Device classification, GMDN code selection and annual registration fee calculation
• Great Britain and Northern Ireland dual-pathway design and UK(NI) solutions
• Post-market surveillance (PMS) system setup, PMSR/PSUR preparation and vigilance reporting
• Serious incident and field safety corrective action (FSCA) emergency response
• UK regulatory change monitoring and compliance gap assessment

For tailored support with UK UDI planning, registration and conformity documentation, contact GRZAN at info@grzanglobal.com.